Atrium Therapeutics, Inc. (RNA) Financial Statements

Atrium Therapeutics, Inc. (RNA) files with the U.S. Securities and Exchange Commission under CIK 0002093101. 10KGenie shows its quarterly statements from SEC filings.

No annual key figures are available in 10KGenie for this company yet. Source: SEC filings.

Open the full financial statements for RNA in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History